The Most Critical Exposure Windows
The second and third trimesters are the periods most consistently associated with neurodevelopmental risk in the acetaminophen research. This is when the fetal brain undergoes the most rapid synaptogenesis (synapse formation), dopaminergic system development, and neural circuit organization — processes that acetaminophen may disrupt through its endocrine-disrupting and prostaglandin-inhibiting effects. The JAMA Psychiatry 2020 cord blood study found that acetaminophen concentrations at birth — reflecting third-trimester exposure — were most strongly predictive of ASD and ADHD risk. The 2018 AJE meta-analysis specifically noted that prolonged use (seven or more days in any trimester) was associated with elevated risk. First-trimester use has also been linked to ADHD in some studies, particularly the Norwegian Mother and Child Cohort data.
If You Don't Remember the Exact Timing
Many mothers took acetaminophen throughout pregnancy — for headaches, fever, back pain, and other discomforts — without keeping records of when or how much. This is normal and expected. You do not need to remember the exact trimester or number of doses to pursue a claim. What matters is that you used acetaminophen during pregnancy at all. Your OB's prenatal records may document acetaminophen recommendations. Pharmacy records (retrievable with a HIPAA authorization) may show fills at points during your pregnancy that correspond to the gestational calendar. Your own recollection, supported by records from pregnancy, is sufficient to establish exposure for litigation intake purposes. An attorney will help you gather the most useful documentation.
Frequently Asked Questions
Related Pages
Tylenol Liver Damage Lawsuit
Acetaminophen — the active ingredient in Tylenol — is the leading cause of acute liver failure in the United States, responsible for approximately 56,000 emergency room visits, 26,000 hospitalizations, and nearly 500 deaths each year. Lawsuits allege that McNeil Consumer Healthcare and parent company Johnson & Johnson failed to adequately warn consumers about the narrow margin between a therapeutic dose and a potentially fatal overdose. Even doses only slightly above the recommended amount, especially when combined with alcohol use or taken across multiple acetaminophen-containing products, can cause catastrophic liver damage. If you or a loved one suffered acute liver failure, liver transplant, or death linked to acetaminophen use, you may be eligible for compensation. These liver damage claims are separate from the Tylenol autism/ADHD litigation — they involve direct injury to the person who took the medication.
Learn moreLearn moreLearn moreLearn moreLearn moreLearn moreTylenol Autism Lawsuit Lawsuit
Acetaminophen — sold under the brand name Tylenol by Kenvue (formerly Johnson & Johnson) and as dozens of store-brand generics by Walmart, CVS, Walgreens, Target, Costco, Meijer, and others — was the most commonly used pain reliever during pregnancy in the United States for decades. Starting with a landmark 2018 American Journal of Epidemiology meta-analysis of 130,000 mother-child pairs, and culminating in a 2021 consensus statement signed by 91 scientists published in Nature Reviews Endocrinology, accumulating evidence linked prolonged prenatal acetaminophen exposure to significantly elevated risks of autism spectrum disorder (ASD) and attention deficit hyperactivity disorder (ADHD). The federal multidistrict litigation, MDL-3043 (In re Acetaminophen — ASD/ADHD Products Liability Litigation) in the Southern District of New York, was dismissed in August 2024 after Judge Denise L. Cote excluded all plaintiffs' general causation experts under the Daubert standard. Critically, the Second Circuit Court of Appeals heard oral arguments on November 17, 2025 — and two of the three judges on the panel openly questioned whether Judge Cote acted too aggressively in excluding the expert testimony. A reversal by the Second Circuit could reinstate thousands of federal cases. Separately, California state courts (Alameda County) and Illinois state courts (St. Clair, Madison, and Cook counties) have active acetaminophen-autism cases proceeding under the Frye admissibility standard, which does not apply the same gatekeeping test that closed the federal MDL. Store-brand acetaminophen users have the same legal claims as Tylenol brand users — the failure-to-warn theory applies equally to Walmart's Equate brand, CVS Health brand, Walgreens brand, Costco Kirkland brand, and all other private-label acetaminophen products.
View full case overview